CD8A and dengue disease: Notably, a previous study reported live-attenuated tetravalent dengue vaccine (TDV)-induced CD8 + T cells targeting NS1, NS3, and NS5 proteins of attenuated DENV-2 (Chu et al., 2015); however, vaccine-induced CD8 + T cell responses were not reported in the subsequent clinical trials of this candidate vaccine.